Cargando…
Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
Pancreatic cancer has the worst prognosis of all gastrointestinal neoplasms. Five-year survival of pancreatic cancer after pancreatectomy is very low, and surgical resection is the only option to cure this dismal disease. The standard surgical procedure is pancreatoduodenectomy (PD) for pancreatic h...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840455/ https://www.ncbi.nlm.nih.gov/pubmed/24281213 http://dx.doi.org/10.3390/cancers2041990 |
_version_ | 1782478516289273856 |
---|---|
author | Nakao, Akimasa |
author_facet | Nakao, Akimasa |
author_sort | Nakao, Akimasa |
collection | PubMed |
description | Pancreatic cancer has the worst prognosis of all gastrointestinal neoplasms. Five-year survival of pancreatic cancer after pancreatectomy is very low, and surgical resection is the only option to cure this dismal disease. The standard surgical procedure is pancreatoduodenectomy (PD) for pancreatic head cancer. The morbidity and especially the mortality of PD have been greatly reduced. Portal vein resection in pancreatic cancer surgery is one attempt to increase resectability and radicality, and the procedure has become safe to perform. Clinicohistopathological studies have shown that the most important indication for portal vein resection in patients with pancreatic cancer is the ability to obtain cancer-free surgical margins. Otherwise, portal vein resection is contraindicated. |
format | Online Article Text |
id | pubmed-3840455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-38404552013-11-26 Selection and Outcome of Portal Vein Resection in Pancreatic Cancer Nakao, Akimasa Cancers (Basel) Review Pancreatic cancer has the worst prognosis of all gastrointestinal neoplasms. Five-year survival of pancreatic cancer after pancreatectomy is very low, and surgical resection is the only option to cure this dismal disease. The standard surgical procedure is pancreatoduodenectomy (PD) for pancreatic head cancer. The morbidity and especially the mortality of PD have been greatly reduced. Portal vein resection in pancreatic cancer surgery is one attempt to increase resectability and radicality, and the procedure has become safe to perform. Clinicohistopathological studies have shown that the most important indication for portal vein resection in patients with pancreatic cancer is the ability to obtain cancer-free surgical margins. Otherwise, portal vein resection is contraindicated. MDPI 2010-11-24 /pmc/articles/PMC3840455/ /pubmed/24281213 http://dx.doi.org/10.3390/cancers2041990 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Nakao, Akimasa Selection and Outcome of Portal Vein Resection in Pancreatic Cancer |
title | Selection and Outcome of Portal Vein Resection in Pancreatic Cancer |
title_full | Selection and Outcome of Portal Vein Resection in Pancreatic Cancer |
title_fullStr | Selection and Outcome of Portal Vein Resection in Pancreatic Cancer |
title_full_unstemmed | Selection and Outcome of Portal Vein Resection in Pancreatic Cancer |
title_short | Selection and Outcome of Portal Vein Resection in Pancreatic Cancer |
title_sort | selection and outcome of portal vein resection in pancreatic cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840455/ https://www.ncbi.nlm.nih.gov/pubmed/24281213 http://dx.doi.org/10.3390/cancers2041990 |
work_keys_str_mv | AT nakaoakimasa selectionandoutcomeofportalveinresectioninpancreaticcancer |